Thirumalai Chemicals Surges! Promoter Family Invests ₹56 Cr, Stock Hits 1-Month High!

CHEMICALS
Whalesbook Logo
AuthorKavya Nair|Published at:
Thirumalai Chemicals Surges! Promoter Family Invests ₹56 Cr, Stock Hits 1-Month High!
Overview

Thirumalai Chemicals' stock price jumped nearly 6% to a one-month high of ₹250.25 after the company successfully raised ₹56.14 crore through a preferential allotment to its promoter group. Key individuals and trusts within the promoter family acquired shares at ₹296 each. This comes as the company's subsidiary progresses with its new manufacturing facility in West Virginia, USA.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Thirumalai Chemicals Sees Strong Gains After Promoter Investment

Thirumalai Chemicals' stock experienced a significant surge on Wednesday, climbing by nearly 6 percent to reach ₹250.25 per share on the BSE. This marks the highest valuation for the stock in a month, underscoring positive investor sentiment following a strategic fundraising initiative.

The rally was directly linked to the company's successful completion of a preferential share allotment, which brought in ₹56.14 crore. This capital infusion was primarily directed towards the promoter group, reinforcing their commitment to the company's growth and stability.

Financial Boost Through Preferential Allotment

The company's Funds Raising Committee Board gave the green light for the allotment of 1.89 million equity shares. These shares, each with a face value of ₹1, were issued at a price of ₹296 per share, representing a significant premium of ₹295 over the face value. This pricing strategy indicates strong confidence in the company's intrinsic value and future prospects by the allottees.

These newly allotted equity shares are set to enjoy equal footing with all existing equity shares of Thirumalai Chemicals, meaning they will carry the same rights and privileges. The company had previously secured in-principle approval from the relevant stock exchanges for this share issuance on December 16, 2025.

Promoter Group's Substantial Investment

Several key individuals and entities within the promoter group were the primary recipients of these preferential shares. Parthasarathy Rangaswamy and Bhooma Parthasarathy were among the major buyers, acquiring a combined total of 37.8 million shares. Promoter R Sampath, along with Sujata Sampath, also made significant contributions, with R Sampath investing ₹85.99 lakh for 29,054 shares and Sujata Sampath investing ₹44.99 lakh for 15,202 shares.

Further investments came from Rangaswamy Sampath, an individual promoter within a Hindu Undivided Family, who purchased 6,418 shares for ₹18.99 lakh. The Uttara and Mukund Family Trust also participated, receiving 5,067 shares valued at ₹14.99 lakh. This broad participation from the promoter circle highlights a unified belief in the company's direction.

US Manufacturing Facility Update

In parallel to the domestic fundraising, Thirumalai Chemicals also provided an update on its international expansion. The company's subsidiary, TCL Limited, has commenced pre-commissioning and start-up activities for a new manufacturing facility located in West Virginia, USA. This facility is designed to produce Maleic Anhydride (MAN).

The subsidiary anticipates that a portion of the MAN unit will become operational by the end of the current calendar year. The complete start-up and stabilization of the remaining units are projected to occur during the first half of the calendar year 2026, marking a significant step in the company's global manufacturing footprint.

Market Performance and Outlook

Despite the recent positive movement, Thirumalai Chemicals' share price has declined by 24.72 percent year-to-date. However, the current three-day winning streak, coupled with trading volumes significantly above the 30-day average—standing at 5.7 times the average today—suggests a potential turnaround in momentum. The Relative Strength Index (RSI) currently sits at 52.1, indicating a neutral market position before this latest surge.

The company previously touched a 52-week high of ₹340.55 on January 3, 2025, and a low of ₹201.30 on March 3, 2024. The current price action positions it favorably within its 52-week trading range.

Impact
This news has a positive short-term impact on Thirumalai Chemicals' stock, driven by promoter confidence and capital infusion. The ongoing expansion in the US offers potential for long-term growth and diversification. The stock may see continued investor interest, although its year-to-date performance indicates underlying market challenges. Impact Rating: 7/10

Difficult Terms Explained

Preferential Allotment: A method where a company issues shares to a select group of investors (not the general public) at a predetermined price, often a premium.

Promoter Group: Individuals, institutions, or entities that hold a significant stake in a company and exercise control over its management and operations.

Maleic Anhydride (MAN): A key industrial chemical used in the production of unsaturated polyester resins, coatings, and other materials.

Relative Strength Index (RSI): A momentum indicator used in technical analysis to measure the speed and change of price movements, typically ranging from 0 to 100.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.